June 2, 2022
Commonly disregarded as a side-thought for drug manufacturers and clinicians, sex plays a key part in the efficacy of medicine.
May 4, 2022
Learn how Interactive Response Technology (IRT) plays a vital role in modern clinical trials.
April 7, 2022
Last week saw the USFDA submit its request for a budget of $8.4 billion as part of the President’s fiscal year 2023 budget. Is that 34% increase over 2022’s funding really needed?
March 3, 2022
Join us at DCAT 2022. We'll be there to conduct high-level, private, strategic meetings about all things pharma related!
February 10, 2022
With the aim of supporting their Drug Competition Action Plan, the FDA has provided clarification and updated guidance for abbreviated new drug application (ANDA).
January 19, 2022
With approximately 200 companies, organizations, institutions and service providers, BioCT keeps policymakers and influencers abreast of the latest developments in the bioscience community.
January 6, 2022
The entry of big tech into the pharmaceutical space is growing at an alarming pace, with the pandemic seeming to speed up the collaboration more than ever before.
December 20, 2021
Thank you for a fantastic 2021, may your holidays’ sparkle with joy and laughter and we’ll see you right back here in 2022.
October 7, 2021
As pharma companies are facing several forces that require them to rethink the offshore operating model they have built up over decades and prepare for more domestic manufacturing and supply, we ask the question: is there a middle ground that works for all?
September 23, 2021
The testing of drugs to control and limit the level of genotoxic impurities and prevent objectionable levels of nitrosamine impurities is now standard operating procedure.
September 8, 2021
Unlocking a world of potential in the pharmaceutical industry, we’re proud to introduce you to a new generation of unrivaled stateside pharma services.